Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Improving the maintenance of weight lost in behavioral treatment of obesity
In pharmacology, steady state is typically reached after 4 to 5 half-lives
Adults who are overweight (BMI 27 kg/m) and have at least one weight-related health condition (e.g., high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea)
Each adds another hormone pathway to enhance weight loss effects
Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist targeted for adults dealing with obesity or those who are overweight and have at least one weight-related health condition
US$ 26.69
US$ 22.59
US$ 26.48
US$ 20.44
US$ 29.38
